Comparison of tocilizumab and tumour necrosis factor inhibitors in rheumatoid arthritis: a retrospective analysis of 1603 patients managed in routine clinical practice

Efficacy and effectiveness of tumour necrosis factor inhibitors in the treatment of rheumatoid arthritis in randomized controlled trials and routine clinical practice

Rheumatology ◽

10.1093/rheumatology/kew467 ◽

2017 ◽

pp. kew467 ◽

Cited By ~ 5

Author(s):

Kalle J. Aaltonen ◽

Suvi Ylikylä ◽

Jaana Tuulikki Joensuu ◽

Pia Isomäki ◽

Laura Pirilä ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Clinical Practice ◽

Randomized Controlled Trials ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Routine Clinical Practice ◽

Controlled Trials ◽

Randomized Controlled ◽

FRI0220 Sustained clinical efficacy after multiple courses of rituximab in rheumatoid arthritis patients with inadequate response to tumour necrosis factor inhibitors: 2-year data from the repeat (repeated courses in routine clinical practice) study

10.1136/annrheumdis-2013-eular.1347 ◽

2013 ◽

Vol 72 (Suppl 3) ◽

pp. A447.3-A448

Author(s):

C. Codreanu ◽

I. Ancuta ◽

R. Ionescu ◽

Keyword(s):

Rheumatoid Arthritis ◽

Clinical Practice ◽

Tumour Necrosis Factor ◽

Clinical Efficacy ◽

Tumour Necrosis ◽

Routine Clinical Practice ◽

Inadequate Response ◽

Practice Study ◽

Faculty Opinions recommendation of The effectiveness of leflunomide as a co-therapy of tumour necrosis factor inhibitors in rheumatoid arthritis: a population-based study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1104777.560749 ◽

2008 ◽

Author(s):

Geoff Littlejohn

Keyword(s):

Rheumatoid Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Population Based ◽

Population Based Study ◽

Immediate treatment with tumour necrosis factor inhibitors in synthetic disease-modifying anti-rheumatic drugs-naïve patients with rheumatoid arthritis: results of a modified Italian Expert Consensus

Rheumatology ◽

10.1093/rheumatology/key076 ◽

2018 ◽

Vol 57 (Supplement_7) ◽

pp. vii32-vii41

Author(s):

Alessandra Bortoluzzi ◽

Guido Valesini ◽

Salvatore D’Angelo ◽

Bruno Frediani ◽

Laura Bazzichi ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Expert Consensus ◽

Disease Modifying ◽

The risk of acute coronary syndrome in rheumatoid arthritis in relation to tumour necrosis factor inhibitors and the risk in the general population: a national cohort study

Arthritis Research & Therapy ◽

10.1186/ar4584 ◽

2014 ◽

Vol 16 (3) ◽

pp. R127 ◽

Cited By ~ 43

Author(s):

Lotta Ljung ◽

Johan Askling ◽

Solbritt Rantapää-Dahlqvist ◽

Lennart Jacobsson ◽

Keyword(s):

Rheumatoid Arthritis ◽

Acute Coronary Syndrome ◽

Cohort Study ◽

General Population ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Coronary Syndrome ◽

National Cohort ◽

Tumour necrosis factor inhibitors and risk of serious infection in rheumatoid arthritis

International Journal of Rheumatic Diseases ◽

10.1111/j.1756-185x.2009.01457.x ◽

2010 ◽

Vol 13 (1) ◽

pp. 12-26 ◽

Cited By ~ 15

Author(s):

Veera S. KATIKIREDDI ◽

Samuel L. WHITTLE ◽

Catherine L. HILL

Keyword(s):

Rheumatoid Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Serious Infection ◽

AB0526 Sustained efficacy responses and a consistent safety profile with rituximab repeat treatment over 5 years in patients with rheumatoid arthritis and an inadequate response to tumour necrosis factor inhibitors in the reflex study:

10.1136/annrheumdis-2012-eular.526 ◽

2013 ◽

Vol 71 (Suppl 3) ◽

pp. 668.6-668

Author(s):

E. Keystone ◽

S.B. Cohen ◽

P. Emery ◽

J.M. Kremer ◽

M. Dougados ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumour Necrosis Factor ◽

Safety Profile ◽

Tumour Necrosis ◽

Inadequate Response ◽

Sustained Efficacy ◽

Repeat Treatment ◽

Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial

The Lancet ◽

10.1016/s0140-6736(12)61424-x ◽

2013 ◽

Vol 381 (9865) ◽

pp. 451-460 ◽

Cited By ~ 393

Author(s):

Gerd R Burmester ◽

Ricardo Blanco ◽

Christina Charles-Schoeman ◽

Jürgen Wollenhaupt ◽

Cristiano Zerbini ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Active Rheumatoid Arthritis ◽

Inadequate Response ◽

Phase 3 ◽

When patients with rheumatoid arthritis fail tumour necrosis factor inhibitors: what is the next step?

10.1136/ard.2008.098111 ◽

2008 ◽

Vol 67 (11) ◽

pp. 1497-1498 ◽

Cited By ~ 20

Author(s):

J. S Smolen ◽

M. E Weinblatt

Keyword(s):

Rheumatoid Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Golimumab in patients with active rheumatoid arthritis who have previous experience with tumour necrosis factor inhibitors: results of a long-term extension of the randomised, double-blind, placebo-controlled GO-AFTER study through week 160

10.1136/annrheumdis-2011-200956 ◽

2012 ◽

Vol 71 (10) ◽

pp. 1671-1679 ◽

Cited By ~ 38

Author(s):

Josef S Smolen ◽

Jonathan Kay ◽

Robert B M Landewé ◽

Eric L Matteson ◽

Norman Gaylis ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Active Rheumatoid Arthritis ◽

Previous Experience ◽

Double Blind ◽

Double Blind Placebo ◽